Transfersome
Transfersome is a type of drug delivery system that uses ultradeformable liposomes to deliver drugs across the skin. This technology was developed by IDEA AG, a German pharmaceutical company, and has been used in a number of products, including Tranfermal, a non-invasive pain relief patch.
History[edit]
The concept of transfersomes was first introduced in the early 1990s by Gregor Cevc and his colleagues at IDEA AG. The goal was to create a drug delivery system that could deliver drugs across the skin without the need for injections or other invasive procedures. The result was the development of ultradeformable liposomes, which are capable of penetrating the skin and delivering drugs to the desired location.
Mechanism of Action[edit]
Transfersomes work by taking advantage of the skin's natural ability to repair itself. When the skin is damaged, it releases certain chemicals that cause the skin cells to shrink and create gaps. These gaps allow the transfersomes to penetrate the skin and deliver the drug.
The transfersomes themselves are made up of phospholipids, which are the same type of molecules that make up the cell membranes in our bodies. This allows the transfersomes to merge with the skin cells and deliver the drug directly into the cell.
Applications[edit]
Transfersomes have been used in a number of different products, including Tranfermal, a non-invasive pain relief patch. This patch uses transfersomes to deliver the active ingredient, diclofenac, directly to the site of pain. This allows for faster and more effective pain relief compared to traditional oral medications.
Other potential applications for transfersomes include the delivery of insulin for diabetes patients, vaccines, and chemotherapy drugs for cancer patients.
Advantages and Disadvantages[edit]
One of the main advantages of transfersomes is that they allow for non-invasive drug delivery. This can be particularly beneficial for patients who have difficulty swallowing pills or who are afraid of injections.
However, there are also some disadvantages to this technology. For example, the effectiveness of transfersomes can be affected by the condition of the patient's skin. If the skin is too dry or damaged, the transfersomes may not be able to penetrate effectively.
See Also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


